Search

Author/Creator Voss, Martin H.

1. A phase 2, randomized trial evaluating the combination of dalantercept plus axitinib in patients with advanced clear cell renal cell carcinoma. Issue 14 (5th April 2019)

Authors:
Voss, Martin H.; Bhatt, Rupal S.; Vogelzang, Nicholas J.; Fishman, Mayer; Alter, Robert S.; Rini, Brian I.; Beck, J. Thaddeus; Joshi, Monika; Hauke, Ralph; Atkins, Michael B.; Burgess, Earle; Logan, Theodore F.; Shaffer, David; Parikh, Rahul; Moazzam, Nauman; Zhang, Xiaosha; Glasser, Chad; Sherma...
Journal:
Cancer
Issue:
Volume 125:Issue 14(2019)
Page Start:
2400
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. A Phase Ib Study of BEZ235, a Dual Inhibitor of Phosphatidylinositol 3-Kinase (PI3K) and Mammalian Target of Rapamycin (mTOR), in Patients With Advanced Renal Cell Carcinoma. (10th June 2016)

Authors:
Carlo, Maria I.; Molina, Ana M.; Lakhman, Yulia; Patil, Sujata; Woo, Kaitlin; DeLuca, John; Lee, Chung-Han; Hsieh, James J.; Feldman, Darren R.; Motzer, Robert J.; Voss, Martin H.
Journal:
Oncologist
Issue:
Volume 21:Number 7(2016)
Page Start:
787
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. A Phase Ib Study of BEZ235, a Dual Inhibitor of Phosphatidylinositol 3‐Kinase (PI3K) and Mammalian Target of Rapamycin (mTOR), in Patients With Advanced Renal Cell Carcinoma. (10th June 2016)

Authors:
Carlo, Maria I.; Molina, Ana M.; Lakhman, Yulia; Patil, Sujata; Woo, Kaitlin; DeLuca, John; Lee, Chung‐Han; Hsieh, James J.; Feldman, Darren R.; Motzer, Robert J.; Voss, Martin H.
Journal:
Oncologist
Issue:
Volume 21:Number 7(2016)
Page Start:
787
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Clinical features, presentation, and tolerance of platinum‐based chemotherapy in germ cell tumor patients 50 years of age and older. Issue 14 (19th April 2013)

Authors:
Feldman, Darren R.; Voss, Martin H.; Jacobsen, Erin P.; Jia, Xiaoyu; Suarez, J. Andres; Turkula, Stefan; Sheinfeld, Joel; Bosl, George J.; Motzer, Robert J.; Patil, Sujata
Journal:
Cancer
Issue:
Volume 119:Issue 14(2013)
Page Start:
2574
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Clinical features, presentation, and tolerance of platinum‐based chemotherapy in germ cell tumor patients 50 years of age and older. Issue 14 (19th April 2013)

Authors:
Feldman, Darren R.; Voss, Martin H.; Jacobsen, Erin P.; Jia, Xiaoyu; Suarez, J. Andres; Turkula, Stefan; Sheinfeld, Joel; Bosl, George J.; Motzer, Robert J.; Patil, Sujata
Journal:
Cancer
Issue:
Volume 119:Issue 14(2013)
Page Start:
2574
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Correction to: Safety and efficacy of nivolumab in combination with sunitinib or pazopanib in advanced or metastatic renal cell carcinoma: the CheckMate 016 study. Issue 1 (14th March 2019)

Authors:
Amin, Asim; Plimack, Elizabeth R.; Ernstoff, Marc S.; Lewis, Lionel D.; Bauer, Todd M.; McDermott, David F.; Carducci, Michael; Kollmannsberger, Christian; Rini, Brian I.; Heng, Daniel Y. C.; Knox, Jennifer; Voss, Martin H.; Spratlin, Jennifer; Berghorn, Elmer; Yang, Lingfeng; Hammers, Hans J.
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 7:Issue 1(2019)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Durable response to anti-PD-1 immunotherapy in epithelioid angiomyolipoma: a report on the successful treatment of a rare malignancy. Issue 1 (1st October 2018)

Authors:
Lattanzi, Michael; Deng, Fang-Ming; Chiriboga, Luis A.; Femia, Alisa N.; Meehan, Shane A.; Iyer, Gopa; Voss, Martin H.; Sundatova, Yuliya; Huang, William C.; Balar, Arjun V.
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 6:Issue 1(2018)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Everolimus plus bevacizumab is an effective first‐line treatment for patients with advanced papillary variant renal cell carcinoma: Final results from a phase II trial. Issue 24 (25th September 2020)

Authors:
Feldman, Darren R.; Ged, Yasser; Lee, Chung‐Han; Knezevic, Andrea; Molina, Ana M.; Chen, Ying‐Bei; Chaim, Joshua; Coskey, Devyn T.; Murray, Samuel; Tickoo, Satish K.; Reuter, Victor E.; Patil, Sujata; Xiao, Han; Aghalar, Jahan; Apollo, Arlyn J.; Carlo, Maria I.; Motzer, Robert J.; Voss, Martin H.
Journal:
Cancer
Issue:
Volume 126:Issue 24(2020)
Page Start:
5247
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. Evolving biological associations of upfront cytoreductive nephrectomy in metastatic renal cell carcinoma. Issue 21 (19th July 2021)

Authors:
Silagy, Andrew W.; Kotecha, Ritesh R.; Weng, Stanley; Holmes, Arturo; Singla, Nirmish; Mano, Roy; Attalla, Kyrollis; Weiss, Kate L.; DiNatale, Renzo G.; Patil, Sujata; Coleman, Jonathan A.; Motzer, Robert J.; Russo, Paul; Voss, Martin H.; Hakimi, A. Ari
Journal:
Cancer
Issue:
Volume 127:Issue 21(2021)
Page Start:
3946
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. Molecular Subtypes Improve Prognostic Value of International Metastatic Renal Cell Carcinoma Database Consortium Prognostic Model. (20th February 2017)

Authors:
de Velasco, Guillermo; Culhane, Aedín C.; Fay, André P.; Hakimi, A. Ari; Voss, Martin H.; Tannir, Nizar M.; Tamboli, Pheroze; Appleman, Leonard J.; Bellmunt, Joaquim; Kimryn Rathmell, W.; Albiges, Laurence; Hsieh, James J.; Heng, Daniel Y. C.; Signoretti, Sabina; Choueiri, Toni K.
Journal:
Oncologist
Issue:
Volume 22:Number 3(2017)
Page Start:
286
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗